(Q54316634)

27 May 2018

title

In vitro susceptibility of Helicobacter pylori to the new oral cephalosporins cefpodoxime, ceftibuten and cefixime. (English)

1 reference

27 May 2018

0 references

T U Westblom

1

1 reference

27 May 2018

S Gudipati

series ordinal

2

1 reference

27 May 2018

B R Midkiff

series ordinal

3

1 reference

27 May 2018

publication date

1 September 1990

1 reference

27 May 2018

European Journal of Clinical Microbiology & Infectious Diseases

published in

1 reference

27 May 2018

volume

9

1 reference

27 May 2018

issue

9

1 reference

27 May 2018

page(s)

691-693

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1007/bf01964274

exact match

0 references

cites work

Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone

1 reference

https://api.crossref.org/works/10.1007%2FBF01964274

Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01964274

In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01964274

Guinea pig model for antibiotic transport across gastric mucosa: inhibitory tissue concentrations of clindamycin against Helicobacter pylori (Campylobacter pylori) following two separate dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01964274

Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication

21 January 2018

1 reference

12 December 2020

Chronic gastritis--a pathogenetic approach

1 reference

12 December 2020

Duodenal ulcer, Campylobacter pylori, and the "leaking roof" concept

1 reference

12 December 2020

Cefixime: spectrum of antibacterial activity against 16,016 clinical isolates.

1 reference

12 December 2020

Campylobacter pylori--therapy review

1 reference

12 December 2020

Activity of cefixime (FK 027) for resistant gram-negative bacilli.

1 reference

12 December 2020

Gastric metaplasia in the duodenum and Campylobacter pylori.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01964274

1 reference

27 May 2018

1 reference

27 May 2018